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Abstract
Anthropogenic climate change is one of the most pressing challenges facing humans today.
It is scientifically established that the production of copious amounts of greenhouse gases such as
carbon dioxide (CO2) is the primary cause of global warming. Many of these greenhouse gases are
produced from the combustion of carbon-based fuels and researchers are investigating promising
alternative fuel sources such as hydrogen gas. Hydrogen gas is a clean burning fuel that stores a
significant amount of chemical potential energy. The goal of this project was to synthesize a
protein based photocatalytic hydrogen production system and to characterize the effects of
modifications on the system. Significant progress has been made in developing/synthesizing all of
the components of a three-part photocatalytic system including the photosensitizer, [Ru(4-CH2Br4-(2,2-bipyridine)(2,2-bipyridine)2](PF6)2, the protein rubredoxin, and a newly designed
hydrogen evolution catalyst [Cp*Ir(4,4'-dimethyl-2,2'-bipyridine)Cl]+ designed to link to proteins.
Preliminary characterization of hydrogen production was determined using a standard curve to
detect hydrogen by gas chromatography. Tris(bipyridine)ruthenium(II) in conjunction with a free
cobaloxime catalyst was used to analyze the integrity of the analytical method. Future work will
allow researchers to attach [Cp*Ir(4,4-dimethyl-2,2-bipyridine)Cl]+ to a protein linker and test its
effectiveness for photochemical hydrogen production which will serve as a standard baseline for
future hydrogen production experimentation.
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Introduction
As human society passed through the industrial revolution we began producing excessive amounts
of greenhouse gases such as carbon dioxide, methane, nitrous oxide, and chlorofluorocarbons. In
abundance these gases pervade the atmosphere locking heat onto the surface of the earth and
raising global temperatures. Perhaps the most efficient greenhouse gas, carbon dioxide, is a direct
product of the combustion of carbon-based fuels. Following the United Nations decision to take
action against climate change during the Paris Global Climate Agreement, global warming has
become recognized as an international crisis. The United States of America is a major producer of
carbon dioxide with over 6,000 metric tons of carbon dioxide being produced from the combustion
of fossil fuels in 2016 alone.1, 2 The inordinate dependence on fossil fuels has pressed scientists to
seek out viable alternative energy sources. As hydrogen gas (H 2) is clean burning and stores a
tremendous amount of energy in its covalent bond (140MJ/kg) it has become a strong potential
candidate to replace fossil fuels.1, 3 Hydrogen gas can be produced by the reduction of protons
through the following half reaction (Reaction 1).
2𝐻+ + 2𝑒− → 𝐻2

E0red = 0V (Rxn 1)

The clear majority of modern industrial practices produce hydrogen gas through steam-methane
reformation in which water acts as a reducing agent. In this process, high pressure steam is
introduced to methane in the presence of a catalyst to form carbon monoxide and hydrogen gas
(Reaction 2). With a separate catalyst, the carbon monoxide is then reacted with water in a watergas shift reaction (Reaction 3) to produce carbon dioxide and hydrogen gas. 4 Ultimately this
method of producing hydrogen gas requires a large amount of energy, necessitates expensive
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catalysts, and produces significant amounts of carbon dioxide. Therefore, it is necessary to form a
sustainable standpoint and investigate other methods of producing hydrogen gas.
𝐻2𝑂 + 𝐶𝐻4 → 𝐶𝑂 + 3𝐻2 (𝑅𝑥𝑛 2)
𝐻2𝑂 + 𝐶𝑂 → 𝐶𝑂2 + 𝐻2(𝑅𝑥𝑛 3)
Recent efforts in producing hydrogen gas have shifted to the attachment of molecular hydrogen
evolution catalysts to a light sensitive compound called a photosensitizer through a linker as
outlined in Figure 1. 5 In this system, irradiation in the UV-visible region promotes excitation of
electrons on the photosensitizer. As the electrons relax they are transferred to the linker and
ultimately to molecular orbitals localized on the catalyst. Following proton collision with the
catalyst, the catalyst acts as a reducing agent promoting the formation of hydrogen gas. A
sacrificial electron donor provides electrons to the photosensitizer and the cycle continues. As the
efficiencies of such complexes are highly dependent on the synergy of the components it is critical
to understand the role each individual piece plays in order to develop complexes with higher
turnover rates.

Figure 1. Schematic of a typical linked hydrogen evolution complex. In such a system, the PS
represents a light-absorbing molecule called a photosensitizer and the Cat represents a hydrogen
evolution catalyst.
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Photosensitizer
The role of a photosensitizer in a photocatalytic hydrogen production system is to translate
photonic energy into electric potential, passing electrons to the linker and reducing the hydrogen
evolution catalyst. A typical organic photosensitizer is composed of a large pi conjugated system,
ultimately lowering the energy gap between the highest occupied molecular orbital (HOMO) and
the lowest occupied molecular orbital (LUMO) into the UV-Visible range (Figure 2). Excitation
of the HOMO electrons allows for subsequent transfer from a singlet state to unoccupied adjacent
molecular orbitals on neighboring atoms. 6

Figure 2. Simplified molecular orbitals of a pi conjugated system. Excitation results in electron
migration to the LUMO and relaxation to adjacent molecular orbitals through intersystem crossing.
Adapted from Harris’s Quantitative Chemical Analysis. 6

A major driving force behind the synthesis of novel organic photosensitizers came from their use
in photodynamic cancer treatment after it was discovered that these compounds catalyzed the
formation of reactive oxygen species in vivo.7, 8 The introduction of penetrative radiation at the
5

tumor site catalyzes the formation and presence of reactive oxygen species to promote cell death
centered around the tumor.7, 8 One of the first photodynamic therapeutic agents and a classical
example of an organic photosensitizer is photofrin (Figure 3). Today, a large number of
photosensitizer-based cancer therapeutics are available on the market or are in clinical trials.
Stemming in part of the success from the use of photosensitizers as phototherapeutic agents,
research began to shift to investigating their potential use in photocatalytic systems in conjugation
with catalysts designed for carbon dioxide reduction or promoting the hydrogen evolution reaction.

Figure 3. Chemical structure of Photofrin an established photodynamic cancer therapeutic agent.

One of the first organic dyes to demonstrate viable quantium yields and turnover rates in
photocatalytic hydrogen production systems was Eosin Y, a brominated derivative of the
fluorophore fluorescein (Figure 4). In aqueous conditions Eosin Y contains a major absorption
peak at 524nm. As UV-visible light emitted by the sun overlaps this region Eosin Y is an ideal
candidate for solar driven hydrogen production.9, 10 The efficiency of hydrogen evolution systems
is often evaluated through the quantum yield, quantum efficency, and turnover rate of the system.
The quantum yield of a photosensitizer is the number of photons emitted per photon absorbed,
while the quantum efficiency of photochemical system is the number of electrons excited per
6

photon absorbed. Both quantum yield and quantum efficiency are reported as ratios from 0-1 or as
percentages. The turnover rate is the number of catalytic cycles per photocatalytic system per unit
of time. Photocatalytic hydrogen production systems using Eosin Y have had variable success
with turnover rates and quantum yields reported up to 900 sec-1 and 4% for nonconnected
molecular systems.9 Unfortunately, Eosin Y exhibits high decomposition and catalysis ceases after
extended use in moleclar systems limiting its use in larger scale production.9, 10 Interestingly, recent
studies conjugating Eosin Y to graphene and nanotube frameworks have led to a decrease in
decomposition suggesting that the degradation process is not innate to Eosin Y.11-13

Figure 4. Structures of A) Rhodamine B) Fluorescein C) Eosin Y and D) rhodamine complex
in which oxygen is substituted for selenium.

Another derived organic dye that has seen a large amount of use in photocatalytic hydrogen
production systems is rhodamine. Historically, rhodamine and its derivatives have been primarily
utilized as imaging agents to probe biological systems. One of the most notable uses of rhodamine
based dyes are in enzyme linked immunosorbent assays to probe antigen-antibody binding
interactions. Similarily to Eosin Y, rhodamine absorbs light in the visible spectrum at around 610
7

nm.

14-16

One of the more effective molecular hydrogen production systems using a modified

rhodamine dye was reported in 2010 by McCormick, et al.
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In this study, a selenium based

rhodamine dye was synthesized and placed in solution with a cobaloxime hydrogen evolution
catalyst. From this system a turnover rate of >5,500 h-1 was reported in conjugation with a very
high quantum efficiency of 33%. Similarily to the Eosin Y systems, the rhodamine dye suffered
from decomposition over extended periods of time.
While dye-sensitized solar cells provide a promising solution for material based photocatalytic
hydrogen production systems, in molecular systems they are limited by extensive decomposition.
Another approach to photosensitizers in molecular hydrogen production lies in the use of transition
metal based complexes. In contrast to the π to π* transition found on dye sensitizers, the
fundamental transition governing a typical transition metal photosensitizer lies in the presence a
symmetry allowed metal-ligand charge tansfer (MLCT) located in UV-visible region. (Figure 5).
This transition allows for excitation of the metals onto the ligand scaffold and subsequent
relaxation of electrons onto a linker or hydrogen evolution catalyst.18, 19
Perhaps the most prototypical and ubiquitous transition metal-based photosensitizer utilized in
hydrogen production is tris(bipyridine)ruthenium (II) chloride, ([Ru(bpy)3]Cl2). (Figure 6) Along
with a π to π* and d to d transition located in the UV-Visible spectrum, [Ru(bpy)3]Cl2 contains a
metal-to ligand charge transfer band at around 452 nm that has a large extinction coefficient
(14,600 M−1cm−1) along with a surprisingly long lived excited state (650 ns).19-21 This long lived
excited state and high extinction coefficient has resulted in a myriad of hydrogen evolution systems
with large quantum efficiencies and turnover rates containing [Ru(bpy)3]2+.10, 17, 19, 22
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Figure 5. Simplified molecular orbital diagram of a transition metal complex containing a metal
ligand charge transition. Adapted from Mauro et al. with information from Miessler et al. 18, 23

2+

3+

Figure 6. Structures of the photosensitizers A) [Ru(bpy)3] , B) [Ir(bpy)3] , and C)
[Pt(tBu3tpy)([C≡CC6H4]H)]. In typical systems the para position of one or multiple pyridine
ligands are substituted to allow for conjugation or modification of the electronic structure.
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Hydrogen Evolution Catalysts
Initial hydrogen evolution catalysts were often discovered serendipitously. From these
compounds, redox active molecules were evaluated through kinetic studies of hydrogen
production. The catalytic activity of chloro(pyridine)cobaloxime (III) was discovered under such
principles (Figure 7). Chloro(pyridine)cobaloxime (III) has served as a benchmark in terms of the
stability and rate of hydrogen production in molecular systems for the past several decades.
Chloro(pyridine)cobaloxime (III) was first synthesized by Schrauzer, et al in 1968 and was further
determined to be a highly redox active system.24 Since its characterization a large number of
hydrogen evolution systems have utilized chloro(pyridine)cobaloxime (III). 9, 10, 17, 22 However, as
more recent work has shifted to linked systems the use of chloro(pyridine)cobaloxime (III) has
decreased as research has indicated high ligand lability when connected in the axial position.
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The ligand lability issue is resolved with the attachment in the equatorial position at the cost of
decreased efficiency due to short excited state lifetimes.25

Figure 7. Structure of chloro(pyridine)cobaloxime (III).

10

More recent hydrogen evolution catalysts have been designed on the basis of mimicking the active
sites of natural hydrogenases that catalyze the hydrogen evolution reaction under the premise that
nature has optimized the catalytic process. Hydrogenases are large proteins composed of a
multitude of subunits and active sites. The active sites of typical hydrogenase are composed of
either a single [Fe]-center, a [Fe-Fe]-center, or a [Ni-Fe]-center coordinated by cysteine residues
along with low spin ligands such as carbon monoxide and cyanide along with bridging sulfides
(Figure 8). While [Fe-Fe]-hydrogenases are notoriously sensitive to the presence of oxygen, [NiFe]-hydrogenases demonstrate increased tolerance to aerobic conditions.22

Figure 8. Structures of a (A) typical [Fe-Fe]-hydrogenase active site and (B) a [Ni-Fe]hydrogenase active site observed in natural hydrogenases.

Work has been done to design and synthesize several molecular variants of the [Fe-Fe] active sites
as well as the [Ni-Fe] active sites for use in hydrogen production. One of the first successful biomimetic hydrogen evolution catalysts was synthesized as a variant of a [Fe-Fe] active site by Lyon,
et al in 1999 (Figure 9).26 Another highly impactful biomimetic hydrogen evolution catalyst were
reported by Helm, et al in 2012 in the form of a nickel catalyst utilizing multiple phenyl phosphine
moieties to imitate the electronic and steric properties of a [Ni-Fe] active site (Figure 8). To date,
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this catalyst has demonstrated one of the highest turnover rates by a molecular catalyst at 1040 sec1

with some derivatives reaching 100,000 sec-1.27

Figure 9. (A) [Fe-Fe] based molecular hydrogen evolution catalysts synthesized by Lyon, et al in
1999.26 B) [Ni-Fe] centered hydrogen evolution catalyst synthesized by Helm, et al in 2012. 27

While some researchers have found success mimicking the active sites of biological hydrogenases
others have taken the approach of creating functional mimics of material and nanoparticle-based
hydrogen evolution catalysts. The water gas shift method of producing hydrogen relies on the use
of various solid metallic surfaces in a form of heterogeneous catalysis. There are several other
catalytic surfaces outside of the water gas shift reaction that have been utilized to promote the
hydrogen evolution reaction. One such surface features molybdenum or tungsten disulfides
deposited on a layer of silica and has demonstrated significant light driven hydrogen evolution
catalysis in conjunction with fluorescein.28 In an effort to reproduce this result on a molecular
level, Eckenhoff, et al synthesized a series of molecular molybdenum hydrogen evolution catalysts
designed to mimic a surface deposit of metal disulfides on silica (Figure 10).29 The most promising
of these complexes, Mo(bdt)2(t-BuNC)2 yielded a turnover rate of 520 sec-1 which falls short of
turnover rates reported from biological hydrogenase mimics but provides a promising alternative
model for synthesizing new hydrogen evolution catalysts.
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Figure 10. Range of molecular dithiol molybdenum-based hydrogen evolution catalysts
synthesized by Eckenhoff et al designed to mimic material-based molybdenum catalysts for
hydrogen production. 29

The catalysts described so far have come about from the applications of redox active systems,
biomimicry, and molecularization of material catalysts. In each case, the catalyst was separate
from the photoactive molecule. With the purpose of combining the active photosensitizer and
hydrogen evolution catalyst Pitman et al constructed the iridium catalyst [Cp*Ir(bpy)(Cl)][Cl]
(Figure 11). The premise of the bipyridine and cyclopentadiene ligands being to provide a pi
conjugated photoactive system while the five-coordinate iridium center acts as the hydrogen
evolution catalyst. The end result was a novel one-component photoelectrocatalyst capable of
producing hydrogen gas with a turnover rate of 16.5 sec

-1

without the use of a secondary

photoactive or catalytic complex. 30
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Figure 11. Structure of the Photoelectrocatalyst, [Cp*Ir(bpy)(Cl)][Cl].

Photocatalytic Hydrogen Production System Linkers
Classical molecular hydrogen production systems are composed of a photosensitizer, a linker, and
hydrogen evolution catalyst. In such system a catalysis necessitates a large number of
intermolecular collisions, not only between the catalyst and substrate, and also between the catalyst
and photosensitizer, as well as the photosensitizer and sacrificial electron donor. In an effort to
decrease the number of collisions needed for catalysis and in turn increase catalytic efficiency,
researchers began to link the hydrogen evolution catalyst to the photosensitizer. This can be done
in several different ways, the simplest of which is a short organic linker or a direct linkage. One
of the first directed linkages reported between a hydrogen evolution catalyst and photosensitizer
was performed by Fihri, et al in 2008 in which a cobaloxime catalyst was linked to a
tris(bipyridine)ruthenium (II) photosensitizer building a foundation for connected reactivity with
a cobaloxime catalyst.31 This work was followed up upon by Mulfort, et al. in 2010 and again in
2016 in which the group built several supramolecular assemblies linking a cobaloxime hydrogen
evolution catalyst to tris(bipyridine)ruthenium at the axial and equatorial positions and
investigated the effect on photoinduced electron transfer (Figure 12).25, 32, 33 It was determined
that while attachment at the equatorial positioned improved complex stability, however, it also
decreased catalytic effectiveness. The catalytic efficiency of supramolecular systems containing
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cobaloxime was determined to be limited by ligand lability and electron back transfer; however,
these studies provided evidence towards improved catalytic efficiency in connected systems. 10

Figure 12. Several of the supramolecular hydrogen production system synthesized by the Mulfort
group in 2010.32

In an effort to move away from direct linkages between components, nanoparticles have also
offered a solution towards increasing catalytic rate as a supramolecular system as they have
demonstrated the capability to not only prevent back transfer of electrons but to also provide a
location for electrons to inhabit prior to proton reduction. Initial interest into nanoparticles as
electrostatic linkers focused on a titanium dioxide core structure (Figure 13). However, cadmium
selenium, and zinc sulfur cores have also been investigated for their use as linkers in conjunction
with cobaloxime catalysts and ruthenium photosensitizers with promising results. 33, 34
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Figure 13. Schematic of a titanium dioxide nanoparticle linking multiple ruthenium-based
photosensitizers and cobaloxime hydrogen evolution catalyst utilizing TEOA as a sacrificial
electron donor. 31
Following a similar rational to nanoparticle-based linkers, researchers have recently become
interested in the utilization of protein linkers under the premise that nature has optimized the
process of electron transfer over the course of millions of years. Furthermore, proteins can be
easily altered through modern day mutagenesis techniques such as site-directed mutagenesis or
CRISPR to allow for optimization of system connectivity and to tune the electron transfer pathway.
One of the highest rates of hydrogen production was reported by Kandemir et al in 2016, in which
a cobalt catalyst attached to a cytochrome c protein provided a turnover of rates of >250,000 h-1.35,
36

Unfortunately, these large turnover numbers required the use of electrocatalytic, rather than

photocatalytic conditions, and similar results have not been reported to date for any photocatalytic
system.
Outside of electrocatalytic conditions, researchers have used small electron transfer proteins such
as flavodoxins and ferredoxins to achieve turnover rates up to 650 h-1 (Figure 14).22, 37, 38 Similarly,
artificial peptide sequences have also been investigated with lower levels of success, 39, 40 likely
due to the fact that these peptides do not provide a binding pocket to stabilize the catalyst within
the protein environment.22 While small electron transfer proteins have been proved to be relatively
effective linkers in hydrogen evolution systems, the highest photocatalytic turnover rates have
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been achieved when using larger charge transfer proteins such as photosystem I (PSI), which have
multiple photoreceptors and elaborately designed electron-transfer pathways.

Figure 14. Protein based photocatalytic hydrogen production system in which ferredoxin is used
to link a molecular cobaloxime hydrogen evolution catalyst to tris(bipyridine)ruthenium (II).37

Another approach to utilizing proteins as a form of linker in a photocatalytic hydrogen production
system is to use a protein that is photochemically active. Naturally, photosystem I (PSI) has
become a popular photoactive protein for use in such systems as nature has optimized PSI to
become a natural solar panel, using chlorophyll molecules with the ability to absorb visible light
and transfer it to the primary electron donor, P700, with large amounts of electrical potential.41
Utschig, et al, in a series of papers, demonstrates that multiple catalytic units of molecular
cobaloxime or nickel diphosphine catalysts molecules could be connected to PSI through
electrostatic and hydrophobic interactions to create a large macromolecular hydrogen production
system.5, 42, 43 Through the use of such a system PSI was capable of acting as a large electron shuttle
providing electrons to a number of attached catalytic subunits. The most efficient molecular
catalyst system, a cobaloxime-PSI hybrid, yielded a turnover rate of 2.83 sec-1 that persisted over
a period of 1.5 hours before loss of the Co catalyst giving rise the hypothesis that covalent
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attachment of the catalyst may extend catalytic lifetime. The advantages of these systems are
highly apparent, but protein-catalyst degradation is still a major issue to overcome.

Figure 15. PSI-based photocatalytic hydrogen production system in which a hydrogen evolution
catalyst is attached the PSI system that acts as a photosensitizer.5, 42, 43
Synthesis of a [Cp*Ir(bpy)(Cl)][Cl]-Rubredoxin Hydrogen Evolution System.
The aim of this thesis is to synthesize and characterize a hydrogen evolution system utilizing a
[Cp*Ir(bpy)(Cl)][Cl] photoelectrocatalyst in conjunction with a rubredoxin protein. Rubredoxins
are small electron transfer protein (5-6 kDa) found in sulfur metabolizing bacteria. They have
similar properties to ferredoxins except instead of a [2Fe-2S] centers with two iron atoms
coordinated by bridging sulfides and four cysteine protein ligands they contain a single Fe center
coordinated by four cysteine residues. Rubredoxins are thermodynamically and kinetically stable
in an aerobic aqueous environment.

44-46

Recent work has demonstrated that rubredoxins are

capable of acting as a hydrogen evolution catalyst in solution with the substitution of the iron
18

center for nickel.47 Work with ferredoxins and flavodoxins as electron transfer linkers has not yet
shown any ability to directly substitute the coenzymes for another redox active metal for hydrogen
production. Flavodoxins that do not contain a natural internal metal center, but contain a flavin
mononucleotide (FMN) cofactor. Ferredoxins, with an [2Fe-2S] cluster, can catalyze the hydrogen
evolution reaction when linked to a hydrogen evolution catalyst and photosensitizer. 38, 48 As such,
the premise of this work is that the novel [Cp*Ir(bpy)(Cl)][Cl] will act as both a photosensitizer
and a hydrogen evolution catalyst while rubredoxin acts as a location for electron localization and
electron collection during the hydrogen evolution reaction.
To provide supporting evidence for this work, rubredoxin will first be connected to the hydrogen
evolution catalyst chloro(pyridine)cobaloxime(II) as well as a modified version of the
photosensitizer tris(bipyridine)ruthenium(II). Mutations will be made to allow for the presence of
a single cysteine and histidine residue around 12-15 Å from the Fe center. Attachment of
chloro(pyridine)cobaloxime will take place through the substitution of the axial pyridine ligand in
exchange for the imidazole of the histidine. The photosensitizer will then be attached to the
cysteine residue through the nuclear substitution of a bromine built into the bipyridine ligand by
the thiol of the cysteine. This classical method of protein based photocatalytic hydrogen production
will serve as a basis for changes in efficiency in the [Cp*Ir(bpy)(Cl)][Cl]-Rubredoxin system in
which [Cp*Ir(bpy)(Cl)][Cl] will replace the photosensitizer.
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Methods
Expression and Mutagenesis
Digestion of vectors
The wild type DNA sequence for rubredoxin was procured from Invitrogen. To express rubredoxin
the sequence had to be located inside a vector containing a promoting region. The pME-T vector
the rubredoxin gene was received in did not contain such a region. To fix this issue, the received
plasmid along with an empty pET21a(+)-HpDsbG vector (obtained from Addgene, plasmid #
39329) were digested using the two restriction enzymes XhoI and NdeI following a standard
protocol for restriction enzyme digests outlined by New England Bio-Labs.
The received plasmid was dissolved in 50µL of deionized water and mixed by flicking and
centrifuging. Two reaction solutions consisting of the reagents shown in Table 1 were prepared
for both the pEM-T vector containing the rubredoxin gene and the empty pET21a(+)-HpDsbG
(pET21a) vector.
Table 1. Table illustrating the volume of each reagent used in both the pEM-T digest reaction and
the PET21a digest reaction.
Reagent
pEMT-T Reaction Pet21a Reaction
Vector
10uL
28.57uL
NDE I
1uL
2uL
XHO I
1uL
2uL
Cutsmart Buffer
2uL
4uL
Deionized Water
6uL
43uL

The reaction solutions were incubated at 37 °C for one hour. After incubation, the reaction
solutions were loaded into a gel for electrophoresis resulting in several distinct DNA bands as
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shown in Figures 21 and 22. After the digestion, the DNA was purified using a S.N.A.P Gel
Purification kit combined with a standard protocol both purchased from Invitrogen.
The two gel pieces containing the desired DNA were cut out using a clean razor. The resulting
pieces were estimated to be around 100 µL and were transferred to sterile 1.5 mL microcentrifuge
tubes. 250 mL of 6.6 M sodium iodide were added to both microcentrifuge tubes and the resulting
solutions were incubated in a 45°C water bath until melted, at which point they were returned to
room temperature. 525 µL of binding buffer was added to both microcentrifuge tubes and mixed
with gentle inversion. A S.N.A.P purification column was assembled following the instructions
detailed in the Gel Purification Kit and the contents of the microcentrifuge tubes were loaded onto
them. The columns were centrifuged into microcentrifuge tubes for 30 seconds at 10,000 rpm and
the liquid was loaded back onto the columns, the process of centrifugation and loading was
repeated twice more. The columns were then placed into two new microcentrifuge tubes and 40
µL of nuclease free sterile water was added to the column. After which they were then centrifuged
at 10,000 rpm for 2 minutes to elute the DNA into the microcentrifuge tube which was
subsequently placed on ice. To determine the purity and concentration of DNA for use in future
steps the Beer-Lambert Law was used in conjunction with UV-Visible spectroscopy. The BeerLambert Law relates absorbance of a solution to the concentration of a solution in the following
equation:

A = bc
A being absorbance,



(equation 1).

being the molar absorptivity, b being path length, and C being

concentration. UV-visible spectroscopy measurements on protein samples were carried out by
measuring the sample’s absorbance as a function of wavelength of light using a quartz cuvette
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containing a 1 cm path length. While pure DNA shows a maximum absorbance at 260 nm, protein
shows maximum absorbance at 280 nm. Using this method and understanding that the molar
absorptivity of double stranded DNA is 50 µg/mL the concentration of DNA was determined.49
Along with determining a concentration, UV-Vis spectroscopy can give an estimation to the purity
of a sample by comparing the ratio of DNA to protein present in a sample. The amount of protein
present in the sample was determined by measuring the absorbance of light at 280nm. Along with
determining a concentration, UV-Vis spectroscopy can be used to estimate the purity of a sample
by comparing the ratio of DNA to protein present in a sample.
Ligation of gene insert and vector backbone
After both the pET21a(+)HpDsbG vector backbone and rubredoxin gene insert were retrieved and
their concentration and purity determined both the vector and insert were ligated together using an
instant ligation master mix obtained from New England BioLabs along with the associated
protocol.
The ligation reaction consisted of 0.91 µL of 1:10 diluted rubredoxin insert along with 2 µL of the
cut pET21a(+)HpDsbG vector bringing the molar ratio of vector to insert to 1:3. The volume of
the solution was brought up to 5 µL through the addition of nuclease free water and 5 µL of the
ligation master mix was added. The final solution was mixed by pipetting up and down 10 times.
2 µL of the reaction solution was added to a 50 µL aliquot of DH5α competent cells designed for
optimal transformation efficiency and placed on ice for 30 minutes. The cells were then heat
shocked at 42°C for 30 seconds and returned to ice for two minutes to induce transformation. 950
µL of LBA media was added to the microcentrifuge tube and the solution was incubated one hour
with shaking at 37°C. After shaking, 100 µL of the solution was spread on LBA plates and left to
incubate overnight at 37°C to promote colony growth. The following afternoon, a single colony
22

was placed inside a 10 mL solution of LBA media to initiate the creation of a starter culture. The
media solution was left overnight at 37°C with shaking stimulating cell growth.
The DNA was purified by extracting the previous night’s cell culture using an Illustra plasmid
prep mini spin kit bought from the GE Healthcare along with the following procedure supplied by
GE Healthcare.
The cell culture was centrifuged at max speed for 10 minutes and excess supernatant was removed
leaving behind a pellet of cells. The cell pellet was re-suspended in 175 µL of lysis buffer type 7
to begin the process of destroying the cell membranes. After resuspension, the solution was
transferred to a microcentrifuge tube and treated with 175 µL of lysis buffer type 8 and mixed with
gentle inversion until the solution became clear with a white precipitate. 350 µL of lysis buffer
type 9 was added to neutralize the lysis buffer type 8 and immediately mixed by gentle inversion
until the white precipitate was evenly dispersed. The microcentrifuge tube containing the solution
was centrifuged at max speed to isolate the precipitate at the bottom. The cell lysate was removed
by pipetting carefully around the white precipitate, loaded onto a wash column, and centrifuged at
max speed for 30 seconds. After centrifugation, the column was washed with 400 µL of wash
buffer type 9 and centrifuged for 30 seconds at full speed. After washing the column with wash
buffer type 9 and centrifuging, 400 µL of wash buffer type 1 was loaded onto the column and the
column was centrifuged again at max speed. To elute the DNA, 100 µL of elution buffer type 4
was loaded onto the column and left to incubate for 30 seconds. After incubation, the column was
centrifuged one last time at max speed and the flow thru was collected in a new sterile
microcentrifuge tube. The DNA concentration and purity was then determined using UV-visible
spectroscopy by evaluating the concentration of protein (280 nm) and comparing it to the
concentration of DNA (260nm).
23

Transformation of rubredoxin plasmid into BL21 competent cells
The DH5α cell line was designed with DNA replication in mind. In order to express the wild type
rubredoxin protein, the plasmid was transferred to BL21 competent cells which have been
optimized for expression of protein. This was done using the following protocol.
1.2µL (100ng) of the reaction solution was added to a 50 µL aliquot of BL21 competent cells
designed for optimal expression efficiency and left to sit on ice for 30 minutes. The cells were then
heat shocked at 42°C for 30 seconds and returned to ice for two minutes to initiate the
transformation process. 950 µL of LBA media was added to the microcentrifuge tube and the
solution was incubated one hour with shaking at 37°C. After shaking, 100 µL of the solution was
spread on LBA plates and left to incubate overnight at 37°C to promote colony growth. The
following afternoon, a colony was placed inside a 10 mL solution of LBA media to create a starter
culture. The media solution was left overnight at 37°C with shaking stimulating cell growth.
Expression and purification of the wild-type Rubredoxin protein.
To prepare for the expression of the wild type protein, a 1 L solution of LB media containing 0.4%
glycerol and 0.1 M ferric chloride was prepared. One starter culture was poured into the LB media
and the entire solution was incubated at 37°C with shaking. The optical density of the solution was
monitored via UV-Visible spectroscopy until the solution reached an optical density of 0.86. At
this point 1 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) was added to the solution to induce
expression of the rubredoxin gene. The solution was subsequently left to incubate overnight at
18°C with shaking.
The following day the solution was centrifuged at 6900 g for 10 minutes. The supernatant was
pipetted out of the tube and the mass of the cell pellet was determined. The cells were then resuspended in a 50 mM solution of Tris-HCl pH 8.0. A cell lysate solution was prepared by adding
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phenylmethylsulfonyl fluoride (PMSF) to the resuspended pellet to create a 1 mM solution, after
which egg white lysozyme was added to the solution to create a final concentration of 0.3 mg/ml.
Further cell lysis was induced by sonicating the cell extract with six 30 second cycles of ultrasonic
pulses followed by 5-minute cooling cycles on ice.
To prepare for purification a column containing a nickel-NTA resin was equilibrated with a
solution containing a 20 mM potassium phosphate, 10 mM imidazole, and 10% glycerol at a pH
of 8.0. The cell lysate was slowly loaded onto the column followed by a wash buffer containing a
solution of 20 mM potassium phosphate, 25 mM imidazole and 10% glycerol, pH 8.0. After the
wash buffer drained through an elution solution containing 20 mM potassium phosphate, 250 mM
imidazole, and 10% glycerol, pH 8.0 was washed through the column. Fractions were collected
throughout this process.
To concentrate the rubredoxin protein, 4 mL of fractions containing the rubredoxin, collected
during the elution step were placed into molecular weight filters with a 3000 Da cutoff. The filters
were centrifuged at 4,000 rpm for 20 minutes. This process was repeated until the fractions were
completed concentrated. To estimate the concentration of the protein sample a Bradford assay was
used16. A Bradford assay is performed by incubating protein samples with a colorimetric dye
reagent and measuring the absorbance of the dye-protein adduct at 595 nm. The dye absorbance is
proportional to the amount of protein present in solution. By knowing the protein concentration
associated with each absorbance, an unknown concentration of a protein can be determined.
The first step of running a Bradford assay is to create a standard curve. This was done by
combining 800 µL of varying concentrations of bovine serum albumin with 200 µL of Bradford
assay dye, incubating 10 minutes at room temperature, and measuring the absorbance at 595 nm
with UV-Vis spectroscopy. The concentrations of bovine serum albumin used were 2 µg/mL, 4
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µg/mL, 6 µg/mL, 8 µg/mL, and 10 µg/mL. Using Microsoft Excel, the concentration of protein to
absorbance was plotted and a standard curve was obtained. After a standard curve was obtained,
concentrated rubredoxin protein was diluted 1:50 and 800 µL of the diluted protein was added to
200 µL of dye. The final solution was incubated for 10 minutes at room temperature and the
absorbance was measured at 595 nm using UV-Vis spectroscopy. This dilution was necessary to
produce a solution a solution with an absorbance within the range of the standard curve. Using the
standard curve, the concentration of rubredoxin was estimated in mg/mL.
To determine the purity of the rubredoxin protein sodium dodecyl sulfate (SDS) polyacrylamide
gel electrophoresis was performed. The samples included the wash, flow, supernatant, pellet, and
elution fractions. 50 µL of each sample was added to 50 µL of 2x SDS dye. Samples were heated
at 85°C for 10 minutes before being loaded onto the gel. The gel was run until the tracking dye
was present at the bottom of the gel. Once finished, the gel was placed into a plastic container
containing Coomassie stain and incubated for one hour with shaking. The liquid was subsequently
drained off and the gel was exposed to a destaining solution containing 45% methanol, 45% water
and 10% acetic acid in order to remove excess dye. A picture was then taken of the gel with a
Pharos FX molecular imager (Bio-Rad).
Mutagenesis of the wild type Rubredoxin DNA
In order to successfully connect the modified tris(bipyridine)ruthenium photosensitizer and the
catalyst chloro(pyridine)cobaloxime to the protein rubredoxin, two mutations must be introduced
to the rubredoxin protein. First the serine at position 22 must be changed to a cysteine and second,
the aspartic acid at position 35 must be changed to a histidine. To make these two mutations the
following primers (Figure 16) containing the desired mutation were ordered from Invitrogen.
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Aspartic Acid to Histidine: Changing 159G to 159C
Sequence:
5’TTTGAAGATCTGCCGCATGATTGGGCATGTCCG3’
3’AAACTTCTAGACGGCGTACTAACCCGTACAGGC5’
Primers
5’ TTTGAAGATCTGCCGCATGATTGGGCATGTCCG 3’Tm:77°C: 52% GC 33bp in length:
Anneal at 72°C (Calculated Tm 79°C)
3’ AAACTTCTAGACGGCGTACTAACCCGTACAGGC 5’Tm:75°C: 52% GC 33bp in length:
Anneal at 72°C (Calculated Tm 79°C)
Serine to Cysteine: changing 159G to 159C
Sequence:
5’GCAAAAGGTGATCCGGATTGCGGTATTAAACCGGGTACAAAATTT3’
3’CGTTTTCCACTAGGCCTAACGCCATAATTTGGCCCATGTTTTAAA5’
Primers
5’GCAAAAGGTGATCCGGATTGCGGTATTAAACCGGG3’Tm:77°C: 51% GC 35bp in length:
Anneal 72°C (Calculated Tm 80°C)
3’CGTTTTCCACTAGGCCTAACGCCATAATTTGGCCC5’Tm:77°C: 51% GC 35bp in length:
Anneal 72°C (Calculated Tm 80°C)

Figure 16. Primers utilized to generate rubredoxin mutations.

A Quik-Change II site directed mutagenesis kit was obtained from Agilent Technologies
containing a protocol along with reagents. Reactions containing the reagents and volumes
illustrated in Table 3 were set up inside PCR tubes. The solutions tubes containing the reactions
were placed inside a thermal cycler and the protocol outlined in Table 4 was followed.
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Table 3. Illustration of the reagents and volumes used for the mutagenesis reaction.
Reagent
Control Reaction
Reaction Buffer
5uL
Control Plasmid
2uL
Forward Primer
1.25uL
Reverse Primer
1.25uL
DNTP Mix
1uL
DI water
38.5uL
DNA Polymerase
1uL

S22C
5uL
1uL
1uL
1uL
1uL
40.5uL
1uL

D35H
5uL
1uL
1uL
1uL
1uL
40uL
1uL

Table 4. Outline of the thermal cycler protocol followed during the PCR step of site directed
mutagenesis.
Segment
1
2

Cycles
1
18

Temperature Time
95°C
95°C
55°C
68°C

Time
30 seconds
30 seconds
1 minute
5 minutes 30 seconds

After thermal cycling was completed the reactions were placed on ice for 10 minutes. 1 µL of the
DpnI restriction enzyme was then added to each reaction in order to digest the parental DNA. The
reactions were mixed via pipetting and incubated at 37°C for 1 hour. After digestion, 1 µL of each
reaction along with a control DNA sample was added to 50 µL of XL1-Blue super competent cells
inside of a 14 mL Falcon polypropylene round bottom tube and placed on ice for 30 minutes. The
reactions and control were then heat shocked at 42°C for 45 seconds and placed back on ice for 2
minutes. 0.5 mL of NYZ+ broth preheated to 42°C was added to each solution and incubated at
37°C with shaking for 1 hour. The solutions were then plated on LBA plates and left to incubate
overnight at 37°C.
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Synthesis of modified tris(bipyridine)ruthenium photosensitizer
In order to connect the photosensitizer tris(bipyridine)ruthenium (Fig. 2) to the protein rubredoxin
a derivative of the compound containing a bromine, [Ru(4-CH2Br-4-(2,2-bipyridine) (2,2bipyridine)2](PF6)2, must be synthesized (Figure. 17).

Figure 17. Representation of the bromine derivative of the photosensitizer [Ru(4-CH2Br-4 -(2,2bipyridine) (2,2-bipyridine)2](PF6)2

4-(bromomethyl)-4-methyl-2,2-bipyridine
The synthesis consisted of two separate steps. First, the ligand 4-(bromomethyl)-4 -methyl-2,2bipyridine was synthesized through the reaction presented in figure 21. As previously reported in
the literature, 1.8 grams of 4,4-dimethyl-2,2-biypyridine, 1.8 grams of N-bromosuccinimide and
0.05 grams of isobutyronitrile were added to a 25 mL round bottom flask and dissolved in 40 mL
of carbon tetrachloride.21 The resulting solution was heated in a nitrogen atmosphere under reflux
at 76°C for 2 hours. The reaction was then cooled to room temperature, filtered with a Hersh
funnel, and evaporated until dry in an oven. The following day the dried product was dissolved in
methylene chloride, loaded onto a silica column, and eluted with a solution of 98:2 (v/v) methylene
chloride/acetone. The fractions obtained from the silica column were rotary vaporized to remove
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the solvent to obtain a final yield of 33%. A 1H-NMR spectrum, a 13C-NMR spectrum, and an IR
spectrum were obtained for characterizing the final product. To better understand the IR spectra,
optimization of the structure and frequency analysis of active IR vibrations was performed under
the premise of a simple harmonic oscillator using B3LYP with the G36* basis set in Gaussian09.
(Yield: 33%) 1H NMR (500MHz, CDCl3 δ): 2.15 (s, 3 H) 4.47 (s, 2 H), 7.35 (unresolved, 2 H),
8.65 (unresolved, 2 H). 13C NMR (500MHz, CDCl3 δ): 20.0, 30.1, 76.5, 119.1, 122.2, 123.4, 124.1,
125.5, 146.5, 149.8. IR(cm-1): 990 (m), 910 (m), 840 (m), 829 (s), 730 (w), 688 (w), 668 (m), 640
(s), 684 (m), 581 (s), 524 (w).
[Ru(4-CH2Br-4-(2,2-bipyridine)(2,2-bipyridine)2](PF6)2
After brominating the ligand, 200 mg of Ru(bpy)2Cl2 was placed inside a round bottom flask along
with 200 mg of silver triflate. The two compounds were then dissolved in 65 mL of anhydrous
acetone and left to stir for 8 hours under nitrogen atmosphere. Over time, a precipitate formed
which was filtered out. 100 mg of 4-(bromomethyl)-4-methyl-2,2-bipyridine was then added and
the solution was stirred for another 2 hours after which the product was precipitated out with the
use of concentrated ammonium hexafluorophosphate. The resulting precipitate was filtered and
left to dry in an oven overnight. A 1H-NMR spectrum and UV-visible spectrum of the resulting
compound were then obtained. (Yield: 13%) 1H NMR (500 MHz, CDCl3 δ): 3.25 (s, 5 H), 7.24 (s,
1 H), 7.45 (s, 1 H ), 7.68 (s, 1 H ), 8.12 (s, 1 H), 8.78 (s. 1 H), 8.65 (s, 1 H). UV/Visible (H2O;
λmax, nm): 460, 425, 285, 240.
Synthesis of [Cp*Ir(bpy)(Cl)][Cl]
Following a similarly reported reaction, 11 mg of the previously synthesized ligand 4(bromomethyl)  -4-methyl-2,2-bipyridine and 20 mg of dichloro-(pentamethylcyclopentadienyl)
-iridium (III) was dissolved in 3 mL of dichloromethane and left to stir for 15 minutes.28 The
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solvent was then evaporated to dryness to obtain a crude yield of 97%. A 1H-NMR spectrum and
UV-visible spectrum was then obtained. The remaining solid was dissolved in a minimal amount
of DCM and hexanes were added dropwise until the precipitation of a minimal amount of yellow
powder. The powder was dried on the Schlenk line and crystalized via vapor diffusion of diethyl
ether on acetonitrile. X-ray crystallographic data was obtained from the crystal. Yield: 13% 1H
NMR (500 MHz, CDCl3 δ): 1.70 (s, undefined), 4.75 (s, 2 H), 5.00 (s, 2 H), 5.29 (s, undefined),
7.23 (s, 1 undefined ), 7.50 (s, 3 H ), 7.61 (s, 1 H), 7.63 (s. 1 H), 7.65 (s, 1 H), 7.99 (s, 1 H), 8.62
(s, 3 H), 8.75 (m, unresolved), 8.85 (s, 1 H), 8.98 (s, 1 H), 9.10 ( s, 1 H), 9.23 (s, 1 H). UV/Visible
(H2O; λmax, nm): 420, 390
Initial GC-TCD Experimentation
A standard sample was created by bubbling 3% hydrogen / 97% nitrogen gas into a 5 mL sealed
cuvette. To provide a baseline for future hydrogen production, a reaction was set up with 8.9 mM
of brominated tris(bipyridine)ruthenium, 7.8 mM chloro(pyridine)cobaloxime and 81 mM
ascorbic acid in a total volume of 3.5 mL at a pH of 7.0. The reaction was charged with a stir bar
and illuminated with electromagnetic radiation at a wavelength of 455 nm with an LED (ThorLabs)
for 24 hours.
An Agilent 7820A GC-TCD was outfitted with a 10 meter in length, 0.32 µm diameter molecular
sieve column with a film thickness of 30 µL and heated to 300°C. Samples were injected into the
GC at 70°C and passed through the column with a nitrogen carrier flow rate of 5 mL/min prior to
being detected by a negative polarity TCD. A standard curve was created by injecting 50 uL, 40
uL, 30 uL, 20 uL and 10 uL of the headspace located on the standard sample utilizing a sealed
syringe. One hundred microliters from the headspace of the chloro(pyridine)cobaloxime and
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tris(bipyridine)ruthenium reaction was then injected into the GC and the reaction efficiency was
evaluated.
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Results
Digestion of vectors
Digestion and electrophoresis of the empty pET21a(+)-HpDsbG vector and rubredoxin containing
pEM-T vector resulted in the two electrophoresis gels visualized in Figure 18. UV-visible
spectroscopy revealed that the concentration of the pET21a(+)-HpDsbG vector following gel
purification was 25 µg/mL with a 260 nm/280 nm ratio of 1.35. UV-Vis spectroscopy also
determined the concentration of the rubredoxin insert following gel purification to be 45 µg/mL
with a 260 nm/280 nm ratio of 1.5.

Figure 18. Visualization of the two restriction enzyme digestion reactions. On the left, the
digestion of the pEM-T vector is pictured loaded with the following lanes. Lane one and two
contain the cut vector, three contains the uncut vector and four contains the ladder. On the right,
the digestion of the pET21a(+)-HpDsbG vector is pictured with lane one containing a ladder, two
containing the uncut vector, and three containing the cut vector.

Ligation of gene insert and vector backbone
Ligation and electrophoresis of the rubredoxin insert and cut pET21a(+)HpDsbG backbone
resulted in the electrophoresis gel pictured in Figure 19.
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Figure 19. Gel formed from the electrophoresis of the ligated pET21a(+)HpDsbG backbone and
rubredoxin insert. Lane one contains the ladder while lanes two and three contain the ligated
plasmid.

UV-Vis spectroscopy determined that the concentration of the ligated vector backbone and
rubredoxin insert was 72.5 µg/mL with a 260 nm/280 nm absorbance ratio of 1.16. Transformation
of the ligated plasmid into BL21 competent cells onto LBA plates resulted in several small sized
colonies which successfully created four 10 mL cell cultures after growing overnight.
Expression and purification of the wild-type Rubredoxin protein
Once one of the 10 mL starter cultures containing the ligated vector backbone and rubredoxin
insert was placed inside of a 1 L flask of enriched LBA media and incubated until the optical
density reached 0.859 after 2 hours and 18 minutes. The cells were induced with IPTG to a final
concentration of 1 mM and allowed to incubate with shaking for 18 hours. The cells were
harvested by centrifugation and following spin down, the resulting cell pellet obtained was 11.35
grams. The procedure listed above in the methods section was followed for the cell lysis and
purification on a Ni-NTA column. After chromatography seven fractions were obtained, including

34

five clear elution fractions. The color of the elution fractions became yellow as they were
concentrated.
The use of a Bradford assay determined the resulting protein concentration to be 55.58 mg/mL.
Polyacrylamide gel electrophoresis and visualization gave the following gel pictured in Figure 23.

Figure 20. Polyacrylamide gel electrophoresis image of various fractions obtained during the
purification of the rubredoxin protein. The lanes are as follows; lane one wash, lane two flow thru,
lane three supernatant, lane four pellet, lanes five through nine elution, and lane 10 the standard.

Mutagenesis of the wild type Rubredoxin DNA
Following site-directed mutagenesis of the rubredoxin plasmid as described in the methods section
above, colonies were visible on both the standard transformation control as well as the standard
mutagenesis control. However, no colonies were visible on the serine to cysteine mutation reaction
or the aspartic acid to histidine mutation reaction. Further work to optimize the mutagenesis
reactions was unsuccessful.
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Synthesis of 4-(bromomethyl)-4-methyl-2,2-bipyridine

Figure 21. Overall synthesis of modified bipyridine ligand.
The reaction of 4,4-dimethyl-2,2-bipyridine with N-bromosuccinimide resulted in the filtering of
a red-orange chunky powder. Purification of this powder resulted in the collection of several
fractions containing an orange tint. Rotary vaporization of these fractions resulted in the formation
of the oily white gum pictured in Figure 22 with a 33% yield. The use of 1H-NMR and 13C-NMR
spectroscopy on this product produced the spectra shown in Figure 23 and 24 while IR analysis of
a KBr pellet yielded the spectrum presented in Figure 25. Finally, geometry optimization and IR
frequency calculations of 4-(Bromomethyl)-4-methyl-2,2-bipyridine were successful using G36*
basis set at B3LYP level. Using the visualization program Avogadro, bands at 678.47 cm−1, 690.22
cm−1 and 754.29 cm−1 were assigned to bending modes in pyridine. On the other hand, band at
569.50 cm−1 corresponded to C – Br stretching.50

Figure 22. Oily white gum product formed from the purification of the reaction between 4,4dimethyl-2,2-bipyridine with N-bromosuccinimide.
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Figure 23. 1H-NMR of 4-(bromomethyl)-4-methyl-2,2-bipyridine in CDCl3

Figure 24. 13C-NMR of 4-(bromomethyl)-4-methyl-2,2-bipyridine in CDCl3
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Figure 25. Infrared spectrum of 4-(bromomethyl)-4-methyl-2,2-bipyridine. Taken as a KBr pellet
from 360cm-1 to 1000cm-1.
Synthesis of [Ru(4-CH2Br-4-(2,2-bipyridine) (2,2-bipyridine)2](PF6)2

Figure 26. Synthesis of modified tris(bipyridine)ruthenium(II) photosensitizer, [Ru(4-CH2Br-4(2,2-bipyridine) (2,2-bipyridine)2](PF6)2.

Over the course of the reaction between Ru(bpy)2Cl2 and silver triflate, a milky white precipitate
slowly appeared at the bottom of the reaction flask. This precipitate was successfully filtered out
leaving behind a red liquid. The reaction of this liquid with 4-(bromomethyl)-4-methyl-2,2bipyridine obtained from the previous step resulted in a slightly lighter red liquid. Precipitation
through the use of excess ammonium hexafluorophosphate resulted in an orange cloudy precipitate
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present in solution. This precipitate was successfully filtered out using filter paper and once dried
formed a neo orange product with a 13.3% yield. 1H-NMR spectroscopy and UV-visible
spectroscopy data is presented in Figure 27 and 28.

Figure 27 1H-NMR spectrum of the brominated tris(bipyridine)ruthenium, [Ru(4-CH2Br-4-(2,2bipyridine) (2,2-bipyridine)2](PF6)2. NMR experiments utilized deuterated chloroform as a
solvent.
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Figure 28. UV-visible spectrum of the brominated tris(bipyridine)ruthenium, [Ru(4-CH2Br-4(2,2-bipyridine)(2,2-bipyridine)2](PF6)2. The solvent for electronic excitation was deionized
water.
Synthesis of the brominated [Cp*Ir(bpy)(Cl)][Cl]

Figure 29. Reaction schematic following the synthesis of [Cp*Ir(bpy)(Cl)][Cl].
Following dissolution of 4-(bromomethyl)-4-methyl-2,2-bipyridine and the iridium precursor in
DCM, the solution rapidly changed colors from a dark orange to a light yellow. The product easily
dried off forming a coating along the glassware and a crude 1H-NMR and UV-visible spectra were
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taken (Figure 30 and Figure 31). 24 hours following vapor diffusion of ether on acetonitrile, thin
needle crystals were observed (Figure 32). X-ray diffraction yielded a poor resolution crystal
structure of indeterminate accuracy.

Figure 30. Crude 1H-NMR spectrum of the brominated [Cp*Ir(bpy)(Cl)][Cl] in deuterated
chloroform.

Figure 31. UV-Vis spectra of a minimal amount of brominated [Cp*Ir(bpy)(Cl)][Cl] dissolved
in DI water.
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Figure 32. Crystals of [Cp*Ir(bpy)(Cl)][Cl] obtained following vapor diffusion of diethyl ether
on acetonitrile.

Initial GC-TCD Experimentation
The raw thermal conductivity data received from the GC-TCD software is presented in Figure 33,
while the standard curve created from the stepwise addition of decreasing amounts of hydrogen
gas is presented in Figure 34. Finally, the TCD data received from the GC-TCD software from the
addition of 100 µL of headspace from the tris(bipyridine)ruthenium – chloro(pyridine)cobaloxime
reaction is presented in Figure 35. Unfortunately, the amount of hydrogen in the sample was
beneath the calibration curve and quantification was not possible due to a lack of time to repeat
the calibration curve with lower concentration of hydrogen gas.
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Figure 33. Reverse polarity TCD data received from the GC-TCD after the stepwise addition of
decreasing amounts of headspace from the standard sample.

Figure 34. Linear relationship between the volume of injected headspace and mass of hydrogen
observed from the standard solution.
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Figure 35. TCD data received from the GC-TCD software from the addition of 100 µL of
headspace from the tris(bipyridine)ruthenium – chloro(pyridine)cobaloxime reaction.
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Discussion
Digestion of vectors and ligation of gene insert
Based on the fact that the pEM-T vector DNA was cut into two pieces (Figure 21), the size of the
pEM-T vector (7,800 base pairs), and the bands position relative to the ladder on the
electrophoresis gel, it is reasonable to estimate that the first band present in the second lane is the
larger portion of the cut vector. In regard to the cut pET21a(+)-HpDsbG vector containing the
rubredoxin insert, the gel shows that lane three containing the cut plasmid contains two distinct
bands indicating a successful digestion. Considering the size of the vector insert (195 base pairs),
the second band is positioned at a reasonable distance from the point of origin suggesting that this
is indeed the rubredoxin insert gene desired. In terms of the ligation of the rubredoxin insert and
the vector backbone (Figure 19), the gel shows only one band present in both the lanes containing
the ligation reaction indicating the success of the reaction. The concentration of the digestions and
ligations throughout this process fell within reasonable levels predicted by past work.15 It is
interesting to note that on all the gels run during this experiment, the bands present in the gel are
consistently positioned slightly higher than the position estimated by the ladder. As this is
consistent throughout this experiment as well as past experiments it was disregarded when
determining the success of the experiment.
Expression of Rubredoxin
Expression of the rubredoxin protein proceeded smoothly resulting in a decent yield of cell pellet
(11.35 g). The visible yellow hue present in the concentrated protein sample gives evidence
towards the rubredoxin protein successfully integrating the iron into its tertiary structure. The
polyacrylamide gel resulting from the SDS gel protein gel electrophoresis shows a very impure
and overloaded sample even with regards to the protein fractions purified through the use of the
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Ni-NTA column (Figure 23). In the future, purifications of wild-type rubredoxin, as well as future
mutated rubredoxin proteins, may require the use of a size exclusion column to remove excess
impurities. The concentration of rubredoxin determined by the Bradford assay (55.58mg/mL) is
indicated as a reasonable value by literature, however this value may be skewed by the impurities
present in the sample.16
Mutagenesis of Rubredoxin
Mutagenesis of the rubredoxin wild type DNA ended up failing multiple times. Electrophoresis of
the digestion reaction occurring after the PCR step has revealed that no non-methylated DNA is
present in solution. This combined with the fact that both control samples provided with the
mutagenesis kit have shown to be successful indicates that the most likely location of error lies in
either the sequence and structure of the mutagenesis primers or an incorrect sequence of rubredoxin
DNA. Since this work completed, other members in the lab group have been successful in mutating
the rubredoxin protein after a shift to expression in SHuffle cells from New England Biolabs,
which are designed to assist in correct protein folding. Expression is currently taking place in a
similar manner to the wild type.
Synthesis of 4-(bromomethyl)-4-methyl-2,2-bipyridine
As the reaction between 4,4-methyl-2,2-bipyridine and N-bromosuccinimide proceeded, the color
gradually evolved from a white slurry to an orange solution indicating the release of bromide ions.
Silica column chromatography of 4-(Bromomethyl)-4-methyl-2,2-bipyridine resulted in a large
loss of product likely due to overlap between the initial orange fraction and the second product
fraction. The 1H-NMR of this compounds reveals (Figure 23) the presence of three aromatic signal
regions (7.0 ppm to 9.0 ppm) corresponding to the three asymmetric aromatic hydrogens, and an
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alkane signal around 4.8 ppm corresponding to the benzylic CH3. Interestingly, there are also two
alkane signals around 2.25 ppm likely corresponding the presence to the benzylic un-brominated
CH3 group as well as a de-brominated CH2 group. This de-brominated peak is supported by the
gradual formation of a red solid in the sample indicating de-bromination occurring over time. The
13

C-NMR spectrum also reveals two alkane carbons and ten aromatic carbons matching with the

predicted structure (Figure 24).
When the infrared spectrum of 4,4-methyl-2,2-bipyridine (Figure 25) is compared to the DFT
vibration calculation, several pyridyl bends from 688cm-1 to 642cm-1 and a C-Br stretch coupled
to several other C-H stretches at 561cm-1 provide consistencies with the structure. Other peaks
appear in similarly predicted regions albeit shifted to higher wavenumbers indicating the necessity
for a higher level of theory and larger basis set.
Synthesis of the brominated tris(bipyridine)Ruthenium
Synthesis of tris(bipyridine)ruthenium, [Ru(4-CH2Br-4-(2,2-bipyridine) (2,2-bipyridine)2]
(PF6)2, proceeded as described in the results with a surprisingly low percent yield. 1H-NMR
spectroscopy indicates the presence of two alkane peaks and several aromatic peaks providing
evidence towards the predicted structure (Figure 27). UV-visible spectroscopy (Figure 28) reveals
a region of π to π* transitions (200 – 225 nm), a region of d to d transitions (350-325nm), as well
as a metal ligand charge transfer band around 452nm. The 1H-NMR data, bright red color, and
UV-visible data is consistent with literature findings.19
Synthesis of the brominated [Cp*Ir(bpy)(Cl)[Cl]
The

reaction

between

4-(bromomethyl)-4-methyl-2,2-bipyridine

and

dichloro-

(pentamethylcyclopentadienyl)-iridium (III) took place surprisingly quickly with a very rapid
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color change. It became quickly becomes apparent when the incorrect stoichiometric ratio was
provided as the presence of excess ligand yielded a brown and orange product compared to the
correct yellow product. Crystallization following workup proceeded smoothly as well.
Unfortunately, the crystal structure was poorly resolved to the point where the presence of bromine
could not be confirmed. NMR spectroscopy of the compound resulted in what appeared to be a
mixture of compounds. This mixture contained identifiable aromatic and alkyl signals suggesting
the presence of the correct species but also multiple species in solution perhaps do to degradation
of 4-(bromomethyl)-4-methyl-2,2-bipyridine prior to ligation (Figure 30). The UV-Visible
spectra (Figure 31) indicates the potential presence of two d – d transitions as well as a π to π*
transitions at lower wavelengths consistent with the presence of cyclopentadiene.
Initial GC-TCD Experimentation
The GC-TCD spectrum revealed the presence of a main peak associated with the presence of
hydrogen for each injection, and also demonstrated a smaller peak with a slightly higher retention
time than hydrogen (Figure 33). This smaller peak is well resolved from the hydrogen peak,
disappears in the later injections, and is likely due the presence of atmospheric air in the sample or
syringe. The plotted standard curve was largely linear with an R2 of 0.997 (Figure 34).
Unfortunately, the 24 hours hydrogen evolution reaction between tris(bipyridine)ruthenium and
chloro(pyridine)cobaloxime did not produce enough hydrogen to reach the lower end of the
standard curve (Figure 35). As this reaction was performed at a pH of 7.0, the lower yield is likely
due to the decreased presence of protons that not only push the reaction forward but stabilize the
catalyst. 25 Furthermore, the reaction was not fully saturated with photosensitizer leading to lower
electron transfer and subsequent yield. In future work a greater concentration of photosensitizer,
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and a lower pH will be utilize along with dilution of the standard solutions to allow for
quantification.
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Conclusions
The procedures for the mutation and expression of a highly versatile electron transfer protein has
been well established and documented using a variety of DNA manipulation and microbiological
techniques. The synthesis of a flexible bipyridine ligand has been optimized and applied to the
synthesis of a ruthenium and an iridium-based photosensitizer. An efficient and effective method
of evaluating hydrogen production has been established with a GC-TCD system. Future work by
the

group

will

focus

on

the

attachment

of

tris(bipyridine)ruthenium

and

chloro(pyridine)cobaloxime to rubredoxin and characterization of the rate of photocatalytic
hydrogen production by GC-TCD. These studies will involve a variety of pH and concentration
optimization as discussed above for the free catalyst and photosensitizer systems.
As described previously, PSI has demonstrated significant hydrogen evolution capability when
electrostatically attached to hydrogen evolution catalysts.
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As previous work indicates the

covalent attachment of system components yields increased hydrogen production, future work will
focus on the attachment of a series of [Cp*Ir(bpy)(Cl)][Cl] molecules to PSI to evaluate its
potential as a photo-electrocatalyst when conjoined to a large protein photoactive protein.
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